Epigallin Canadian Trademark Information

On Monday, October 22, 2012, a canadian trademark registration was filed for Epigallin by SINPHAR PHARMACEUTICAL CO., LT *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1599211. The current status of this trademark filing is Registration published. The correspondent listed for Epigallin is RICHES, MCKENZIE & HERBERT LLP of *********, **********, ***** **** The Epigallin trademark is filed in the description of Pharmaceutical products, namely, preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease and Cerebral palsy; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of the cardiovascular diseases; pharmaceutical preparations for the treatment of disorders of the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, and anemia; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the digestive system, namely, acute gastritis, chronic gastritis, gastric ulcer, duodenal ulcer, chronic gastroenteritis, constipation, hemorrhoid; pharmaceutical preparations for the treatment of the endocrine system diseases, namely diabetes, hyperthyroidism, hypothyroidism, gout, fatty liver; pharmaceutical preparations for use in the treatment, cure, mitigation and prevention of gingivitis, halitosis, Angina Pectoris, heart failure, heart rhythm disorders, high blood pressure; food supplements, namely, anti-oxidants; pharmaceutical products for the prevention and treatment of cancer; germicides; mouthwashes for medical purposes; medicines for human purposes for use in respiratory diseases, liver disease, stomach ulcers, hypertension, mouth infection; pharmaceutical preparations, namely preparations for the treatment of the skin and mucous membranes; pharmaceutical preparations for treating diabetes; diagnostic reagents for clinical laboratory use, diagnostic reagents for medical diagnostic use, diagnostic reagents for medical laboratory use, diagnostic reagents for medical research use; protein dietary supplements; dietary supplements for weight loss; dietary supplements for weight management; dietary suppliements for appetite control; dietary supplements for satiety; dietary supplements for maintaining healthy blood glucose; dietary supplements for maintaining insulin levels; food for babies, namely, milk-based baby food, juice-based baby food, milk powder, canned food for babies; pharmaceutical preparations, namely, mineral-based food supplements .